Inflammation is an important mediator of secondary neurological injury after traumatic brain injury (TBI). Endocannabinoids, endogenously produced arachidonate based lipids, have recently emerged as powerful anti-inflammatory compounds, yet the molecular and cellular mechanisms underlying these effects are poorly defined. Endocannabinoids are physiological ligands for two known cannabinoid receptors, CB1R and CB2R. In the present study, we hypothesized that selective activation of CB2R attenuates neuroinflammation and reduces neurovascular injury after TBI. Using a murine controlled cortical impact (CCI) model of TBI, we observed a dramatic upregulation of CB2R within infiltrating myeloid cells beginning at 72 h. Administration of the selective CB2R agonist, GP1a (1-5 mg/kg), attenuated proinflammatory M1 macrophage polarization, increased anti-inflammatory M2 polarization, reduced edema development, enhanced cerebral blood flow, and improved neurobehavioral outcomes after TBI. In contrast, the CB2R antagonist, AM630, worsened outcomes. Taken together, our findings support the development of selective CB2R agonists as a therapeutic strategy to improve TBI outcomes while avoiding the psychoactive effects of CB1R activation.
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Introduction
Traumatic brain injury (TBI) is a major cause of injury-related deaths and long-term disability. Cerebral edema, a lifethreatening complication that presents in the hours and days after TBI, contributes to elevated intracranial pressure (ICP) (CatalaTemprano et al., 2007; Levin et al., 1991; Saul and Ducker, 1982) , cerebral hypoperfusion (Catala-Temprano et al., 2007) , inadequate tissue oxygenation (Narotam et al., 2009 ), brain herniation (Katayama et al., 1990 Lenzlinger et al., 2001; Sarabia et al., 1988) , and a poor clinical patient prognosis (Eisenberg et al., 1990; Levin et al., 1991; Narayan et al., 2002) . Neither neurosurgical nor medical approaches adequately reduce edema formation or improve cerebral perfusion (Bloch and Manley, 2007; Sahuquillo and Arikan, 2006) . Given the high incidence rate of TBI, novel approaches are needed to ameliorate both the acute and longterm pathological outcomes following TBI.
The initial impact produces immediate mechanical damage and loss of tissue due to necrosis. This is followed by a coordinated set of immune responses that contribute towards both tissue repair and secondary neurological injury. Along these lines, we and others found a temporal and functional association between acute neuronal necrosis and the development of innate immune activation after both pre-clinical and clinical TBI (Braun et al., 2017; Czigner et al., 2007; Kawamata and Katayama, 2006; Laird et al., 2014) . Macrophages are professional phagocytes that aid in clearance of
